Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biothree OD probiotics for chronic constipation in elderly patients
jRCTs031210344Completed
- Sponsor
- TOA Biopharma
- Start
- Sep 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Biothree OD in chronic constipation, sponsored by TOA Biopharma. Started Sep 2021; status: completed.
02
Drugs
Biothree OD
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs031210344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210344.